Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 2022 Oct 11;100(12):777–788L. doi: 10.2471/BLT.22.288447

Tuberculosis care models for children and adolescents: a scoping review

Modèles de prise en charge de la tuberculose chez les enfants et adolescents: analyse exploratoire

Modelos de atención a la tuberculosis para niños y adolescentes: una revisión exploratoria

نماذج رعاية السل للأطفال والمراهقين: مراجعة عن كثب

儿童和青少年结核病护理模式:范围审查

Модели оказания противотуберкулезной помощи детям и подросткам: концептуальная проработка

Courtney M Yuen a,, Daria Szkwarko b, Melanie M Dubois c, Shumail Shahbaz d, Katharine A Yuengling e, Michael E Urbanowski f, Paul A Bain g, Annemieke Brands h, Tiziana Masini h, Sabine Verkuijl h, Kerri Viney h, Yael Hirsch-Moverman e, Hamidah Hussain i
PMCID: PMC9706349  PMID: 36466210

Abstract

Objective

To map which tuberculosis care models are best suited for children and adolescents.

Methods

We conducted a scoping review to assess the impact of decentralized, integrated and family-centred care on child and adolescent tuberculosis-related outcomes, describe approaches for these care models and identify key knowledge gaps. We searched seven literature databases on 5 February 2021 (updated 16 February 2022), searched the references of 18 published reviews and requested data from ongoing studies. We included studies from countries with a high tuberculosis burden that used a care model of interest and reported tuberculosis diagnostic, treatment or prevention outcomes for an age group < 20 years old.

Findings

We identified 28 studies with a comparator group for the impact assessment and added 19 non-comparative studies to a qualitative analysis of care delivery approaches. Approaches included strengthening capacity in primary-level facilities, providing services in communities, screening for tuberculosis in other health services, co-locating tuberculosis and human immunodeficiency virus treatment, offering a choice of treatment location and providing social or economic support. Strengthening both decentralized diagnostic services and community linkages led to one-to-sevenfold increases in case detection across nine studies and improved prevention outcomes. We identified only five comparative studies on integrated or family-centred care, but 11 non-comparative studies reported successful treatment outcomes for at least 71% of children and adolescents.

Conclusion

Strengthening decentralized services in facilities and communities can improve tuberculosis outcomes for children and adolescents. Further research is needed to identify optimal integrated and family-centred care approaches.

Introduction

Of the roughly 10 million people who develop active tuberculosis annually, around one in every six is a child or adolescent aged 0–19 years old.1,2 In 2020, less than half of the children with tuberculosis were diagnosed and treated, and only an estimated 36% of young child contacts eligible for tuberculosis preventive treatment received it.1

When considering how to improve the detection, treatment and prevention of tuberculosis in children and adolescents, policy-makers must recognize that children and adolescents have different health care needs from adults. Tuberculosis diagnosis in children is challenging given the overlap in symptoms with common childhood illnesses, and the higher likelihood of paucibacillary and disseminated disease makes bacteriologic testing difficult.3 Children and adolescents often access the health system differently from adults, as they may attend paediatric or youth clinics and their access may be dependent on a guardian.

Care models that remove barriers to accessing services or completing treatment can help ensure that children and adolescents are diagnosed promptly, treated effectively and receive appropriate preventive care. Three broad strategies that seek to reduce barriers are decentralization of care, integration of care and family-centred care.4 Decentralization refers to provision of services at points in the health system where patients first seek care. These points of first contact are often primary-level or community health centres, outpatient clinics or private general practitioners rather than specialized tuberculosis clinics or hospitals. Integration refers to coordinating care for multiple health conditions. Family-centred care is responsive to the needs of the family affected by tuberculosis. Important components of family-centred care are offering families a choice in what treatment they receive or how it is delivered, as well as addressing their social, psychological and economic needs.

Most of the literature evaluating decentralized, integrated or family-centred care models for tuberculosis has not specifically addressed children or adolescents. A systematic review of adherence interventions for children and adolescents showed that community-based and family-centred interventions promote successful tuberculosis disease treatment;5 however, this review did not encompass diagnostic or prevention outcomes. Other systematic reviews have assessed the impact of community-based case-finding,6,7 decentralized care for multidrug-resistant tuberculosis,8 community-based treatment support,9 integration of tuberculosis and human immunodeficiency virus (HIV) services10,11 and socioeconomic and psychosocial support.1214 However, these reviews have not sought to disaggregate child or adolescent outcomes from adult outcomes and many of the included studies focus on adults. Because children and adolescents have unique needs based on clinical and life stage considerations, it is unclear whether the impact observed for adults translates to children and adolescents.

To address this knowledge gap, we conducted a scoping review to assess the evidence for the impact of decentralized, integrated and family-centred care on child and adolescent tuberculosis outcomes in countries with high tuberculosis burdens. Our objectives were to (i) quantitatively assess the impact of these care models on child and adolescent tuberculosis diagnosis, treatment and prevention outcomes; (ii) describe the varied approaches to implementing these care models; and (iii) identify key gaps in knowledge around the impact of these care models.

Methods

Our objectives were to map out the available evidence around a diverse set of care models and help define how these care models are being implemented in tuberculosis services for children and adolescents. We chose a scoping review because this method is more appropriate than a systematic review for exploring the definitions of decentralized, integrated and family-centred care as they apply to tuberculosis care delivery rather than assessing the evidence around a specific set of approaches defined a priori.15

WHO staff members defined the research question for the review and commissioned an independent group of experts (CMY, HH, YHM, DS) to conduct it. This group of experts submitted a study protocol to WHO for approval before conducting the review.

Search strategy

To develop our search strategy, we first defined key features of decentralized, integrated and family-centred care in consultation with four WHO staff members and three stakeholders with experience working in middle-income country tuberculosis programmes. We developed search terms based on the results of these discussions and by consulting published systematic reviews. We searched PubMed®, Embase®, Web of Science™, WHO regional databases of the Global Index Medicus, Global Health and the Cochrane Central Register of Controlled Trials on 5 February 2021. We reviewed a sample of the first 400 abstracts and 45 articles from the database search to better define the care models, consulting stakeholders to resolve ambiguity. Based on our refined definitions, we supplemented the database search by searching the reference lists of systematic and non-systematic reviews and requesting unpublished data from ongoing studies. The development of the search strategy and search terms are available in our data repository.16 We updated the PubMed® search on 16 February 2022, as all the included studies identified in the original database search were found in PubMed®.

Study selection

We defined seven outcomes of interest related to diagnosis (case notifications in a geographical area, diagnoses in a cohort and delay in tuberculosis diagnosis), treatment (successful treatment for tuberculosis disease) and prevention (tuberculosis preventive treatment initiation, delay in such initiation and tuberculosis preventive treatment completion among contacts). We did not include tuberculosis preventive treatment among children or adolescents living with HIV. We considered individuals aged 0–19 years, encompassing children (0–9 years) and adolescents (10–19 years). To identify feasible approaches for programmes managing large numbers of people with tuberculosis disease or exposure, we limited the review to 74 countries that either had an estimated tuberculosis incidence of ≥ 100 cases per 100 000 population in the 2020 WHO Global Tuberculosis Report (64 countries)17 or appeared on WHO’s list of tuberculosis priority countries for 2016–2020 (48 countries).18

Two authors reviewed abstracts and full-text articles, and any disagreements were arbitrated by a third reviewer. In the abstract review, we included those that reported any outcome of interest and excluded those restricted to populations aged 18 years or older (a conventional definition of adults) since these papers would be unlikely to disaggregate data for just the adolescents 18–19 years old. In the full-text review, for the quantitative assessment, we included comparative studies that reported outcomes of interest for a group that received decentralized, integrated or family-centred care and a group that did not. We also identified non-comparative studies for the qualitative assessment. We included articles in any language. Inclusion and exclusion criteria are available in the data repository.16

Outcome data extraction

We extracted data on study design and setting, care model features and outcomes for available age groups within the 0–19 year range. We extracted numbers of events and people in control and intervention groups, and case notifications for intervention and pre-intervention periods in intervention and control areas. For comparative studies we performed quality assessments with the Cochrane Risk of Bias 2 tool for randomized studies or an adapted Newcastle–Ottawa scale for non-randomized studies (available in the data repository).16

Qualitative analysis

We used a qualitative analysis approach to group interventions into general approaches for evidence synthesis. We assigned codes to intervention components, grouped codes into themes corresponding to general approaches, then grouped these approaches under the parent themes of decentralized, integrated or family-centred care models. For studies reflecting multiple care models, we categorized the study according to the predominant care model described by the authors. We included non-comparative studies in the qualitative analysis for care models where there were fewer than five comparative studies identified. While these studies would not address the impact of the care model, they could contribute to the second objective of describing care delivery approaches.

Calculation of effect estimates

We calculated risk ratios (RR) or incidence rate ratios (IRR) and corresponding 95% confidence intervals (CIs) for the child and adolescent age group. For cohort studies, we calculated RR based on count data. For studies where the outcome was case notifications, we estimated annual IRR based on case notifications during the intervention and pre-intervention periods, assuming the size of the underlying population to remain constant. Where possible, we calculated IRRs adjusted for changes in case notification rate over time in a control area (i.e. the ratio of IRRs between the intervention and control area). To estimate CIs for unadjusted IRRs, we used a large-sample normal approximation. We report exact CIs for estimates based on small numbers of events. Statistical analysis was performed in SAS version 9.4 (SAS Institute Inc., Cary, United States of America).

Results

Study identification

We reviewed 3361 abstracts from database searches and an additional 134 studies referenced by 18 reviews (Fig. 1). We identified 27 published comparative studies1945 and one unpublished data set.46 Many studies described multifaceted interventions and interventions were heterogeneous (Table 1; available at: https://www.who.int/publications/journals/bulletin/). The primary intervention was decentralization for 23 studies,1939,44,46 integration for three studies40,41,45 and family-centred care for two studies.42,43 Because of the small number of studies of integrated and family-centred care models, we incorporated into the evidence synthesis 19 additional studies without comparative outcomes (six studies reporting on integrated models4752 and 13 studies reporting family-centred models;5365 Table 2; available at: https://www.who.int/publications/journals/bulletin/).

Fig. 1.

Flowchart of the selection of articles included in study on tuberculosis care models for children and adolescents

Note: We performed the literature search 5 February 2021 and updated the search 16 February 2022. We identified three out of the 47 included studies (two comparative and one non-comparative) in the search update.

Fig. 1

Table 1. Characteristics of comparative studies included in the scoping review on tuberculosis care models for children and adolescents.

Study Country; setting Study design Population Intervention Comparator Comparative outcomes (age groups available for children or adolescents)
Bayona et al., 200328 Peru; Lima city Prospective cohort study with concurrent comparator Household contacts (all ages) of patients treated for MDR tuberculosis in an individualized treatment programme (North Lima) or a standardized MDR tuberculosis treatment programme (Central Lima) • Home visit for contact screening made when the index patient was enrolled
• Follow-up home visits for contact screening performed by the DOT workers supporting the index patients throughout the index patient’s course of treatment; contacts with symptoms were referred for evaluation
• When index patient was enrolled, symptomatic household contacts were expected to go to health centre on their own
• No home visits; symptomatic contacts were expected to go to health centre on their own
Tuberculosis cases diagnosed among contacts (0–14 years)
Datiko & Lindtjørn, 200937 Ethiopia; Dale and Wonsho, rural districts of Sidama zone Cluster-randomized trial (cluster: communities) Patients (all ages) treated for smear-positive tuberculosis from 30 intervention communities and 21 control communities; in both arms, 10% of patients were children 0–14 years old • Community DOT: tuberculosis patients received DOT from health extension workers at health posts, which are community-based health facilities and the most decentralized level of health system
• Training (2-day) on identifying tuberculosis symptoms, collecting sputum, administering DOT and treatment support provided to health-care workers, laboratory technicians and health extension workers
• Health extension workers gave tuberculosis-related health education
• Tuberculosis patients received DOT from health-care workers at health stations and health centres (more centralized facilities compared with health posts)
• Training provided to health-care workers but not health extension workers (same content as in intervention arm)
• Health extension workers gave tuberculosis-related health education
Patients with treatment success (0–14 years)
Davis et al., 201930 Uganda; Kampala city Cluster-randomized trial (cluster: household) Household contacts (all ages) of patients newly diagnosed with tuberculosis at seven public primary care clinics • Home visits for contact screening were made by CHWs
• All contacts with any tuberculosis symptom, who were < 5 years old or who were living with HIV, had sputum collected in the home and were offered HIV testing in the home
• Sputum test results and follow-up instructions were delivered to participants via an automated SMS system
• Home visits for contact screening were made by CHWs
• All contacts with any tuberculosis symptom, who were < 5 years old or who were living with HIV, were referred to nearby health facilities for sputum testing, HIV testing and clinical evaluation
Tuberculosis cases diagnosed out of contacts (secondary trial outcome) (0–4, 5–14 years)
EGPAF, 201846 Cameroon, Côte D’Ivoire, Democratic Republic of the Congo, India, Kenya, Lesotho, Malawi, Uganda, United Republic of Tanzania, Zimbabwe Pre-post study without control area Children and adolescents 0–14 years old with tuberculosis signs/symptoms attending study health facilities and contacts (0–14 years old for case-finding, 0–4 years old for preventive treatment) • Training on paediatric tuberculosis and supportive supervision for health-care workers. Topics included sample collection, Xpert® MTB/RIF assay, management
• Screening in primary care settings (waiting areas of outpatient department and paediatric wards) and screening in integrated settings (HIV, maternal–child health, nutrition clinics). Screening was performed by health-care workers or CHWs. Children with symptoms were referred for clinical evaluation
• Home visits for contact screening performed by CHWs, who referred for evaluation or preventive treatment
• Supplies for sample collection provided
• Introduction of contact investigation and preventive treatment register, caregiver education materials for preventive treatment
• No explicit description of the pre-intervention care model is given, but pre-intervention situation is likely to have been variable across 10 study countries People who initiated tuberculosis treatment at study facilities, contacts who initiated preventive treatment at study facilities (0–14 years for tuberculosis treatment, 0–4 years for preventive treatment)
Fatima et al., 201629 Pakistan; Lahore, Rawalpindi, Faisalabad and Islamabad districts, which have high concentrations of slums Pre-post study without control area Household contacts (all ages) and people living within 50 m of patients with smear-positive tuberculosis (community contacts) • Screening in homes was done by field workers who visited all residences within 50 m of a patient with smear-positive tuberculosis
• Children with symptoms were referred to a health facility for evaluation, while adults with symptoms had sputum collected in the home
• Passive case-finding (no additional description) Tuberculosis cases notified in study districts (0–14 years)
Hanrahan et al., 201927 South Africa; Vhembe and Waterberg districts of Limpopo Province, largely rural Cluster-randomized trial (cluster: health facilities) Household contacts (all ages) of tuberculosis patients from study health facilities; health facilities (28 intervention, 28 control) comprised those providing essential services and those providing maternity, emergency and 48-hour inpatient care • Home visits for contact screening were implemented in 14 facilities. Up to three home visits were made by the study team, with symptom screening and sputum collected in the home for those with symptoms
• Incentive-based contact tracing was implemented in 14 facilities. Both index patients and contacts received monetary incentives if the contact went to the health facility
• Passive case-finding with symptom-based screening was also done at health facility
• Passive case-finding with symptom-based screening for all people presenting to health facility People who initiated tuberculosis treatment in study facilities (0–5, 6–20 years)
Islam et al., 201719 Bangladesh; one urban slum area in Dhaka, two rural sites in Kalai and Bashail subdistricts Pre-post study without control area Children with tuberculosis signs or symptoms attending selected primary care facilities • Training (twice per year) on child tuberculosis management was provided for graduate doctors, field workers, laboratory technicians, radiologists, medical assistants, village doctors and drug sellers
• Community awareness of childhood tuberculosis was promoted through community health education sessions with mothers of young children, teachers, students and religious and community leaders
• Procurement support via quarterly meetings with local managers
• Primary care health workforce had no training on childhood tuberculosis management
• Primary care facilities experienced shortages of tuberculin and radiology supplies
Tuberculosis cases at study facilities; unclear if reported outcome is diagnosis or treatment initiation (no definition of children is stated)
Jeena & Naidoo, 201634 South Africa; peri-urban community including low-cost state housing and informal settlements Retrospective cohort study with historic comparator Tuberculosis patients 0–15 years old who received doorstep or clinic-based tuberculosis care • Home visits to patients made by community caregivers or nurses 2–3 times per week. At visits, they recorded basic clinical history, evaluated adherence and addressed adherence issues, offered tuberculosis education and dispensed medications • Patients received care from primary care clinics. Patients visited clinics once a month to collect medications Standard tuberculosis disease treatment outcomes (< 1, 1–6, 7–12, 13–15 years)
Joshi et al., 201520 Nepal; seven intervention districts having high poverty, higher population density and lower case notification rates compared with the national average; seven control districts had no active case-finding activities being implemented Pre-post study with control area Household contacts 0–14 years old and children and adolescents 0–14 years old with tuberculosis signs or symptoms • Home visits for contact screening (0–14 years) performed by volunteers, with referral to health facilities or sputum collected in the home
• Screening in communities via mobile camps equipped with doctors, microscopy and tuberculin skin test
• Screening in homes for families with a member living with HIV performed by volunteers
• Screening in schools performed by volunteers
• Screening in maternal–child health clinics performed by maternal–child health providers; children with tuberculosis symptoms referred to tuberculosis centre for diagnosis
• Private sector practitioners were reimbursed for tuberculosis diagnoses
• No active case-finding activities were being implemented Tuberculosis cases notified in study districts (0–4, 5–14 years)
Ketema et al., 202041 Ethiopia; Addis Ababa city Stepped-wedge trial (cluster: health facilities) Children 0–4 years old with tuberculosis signs or symptoms attending integrated maternal, neonatal and child illnesses clinics in 30 health facilities • Training (3-day) on childhood tuberculosis for integrated maternal, neonatal and child illnesses health-care workers
• Supplies: reference materials, nasogastric aspiration supplies and new integrated maternal, neonatal and child illnesses registers with a tuberculosis screening column were provided
• This trial also included a component of training health-care workers in the tuberculosis clinic on childhood tuberculosis, but this did not represent a care model of interest, so only the integrated maternal, neonatal and child illnesses outcomes were considered
• No description of pre-intervention standard practice in integrated maternal, neonatal and child illnesses clinics with respect to tuberculosis screening Tuberculosis cases diagnosed among children attending integrated maternal, neonatal and child illnesses clinics (0–4 years)
Khan et al., 201221 Pakistan; Korangi and Bin Qasim areas of Karachi comprised the intervention area; Landi and Shah Faisal areas of Karachi comprised the control area. Both are lower-income urban areas Pre-post study with control area People (all ages) with tuberculosis signs or symptoms attending Indus Hospital (a private free hospital that is also a national tuberculosis programme reporting centre) or 50 private family clinics (primary care facilities) in the intervention area • Screening in primary care settings performed by incentivized screeners (community members hired for the intervention) for all attendees of 50 private family clinics and the Indus Hospital outpatient department
• Anyone with prolonged cough, prior tuberculosis history or a family member with tuberculosis was evaluated for tuberculosis. Children were referred to Indus Hospital specialists, while adults had spot sputum collected at the screening point
• Community awareness promoted through advertisements, posters, flyers, banners, etc. encouraging people with ≥ 2 weeks of cough to seek care at family clinics or Indus Hospital
• No explicit description of the pre-intervention care model is given Tuberculosis cases notified by Indus Hospital, one of the five national tuberculosis programmes reporting centres in the intervention area (0–14 years)
Maha et al., 201922 Papua New Guinea; East New Britain Province Pre-post study without control area People (all ages) with tuberculosis signs or symptoms attending the provincial hospital (centralized) and two decentralized health facilities • Training courses on tuberculosis management, HIV testing and integrated management of adult illness was conducted for health-care workers
• Hospital specialists provided weekly medical consultation and patient review for decentralized facilities
• Xpert® MTB/RIF testing was made available for all presumptive tuberculosis cases
• Community awareness campaign to encourage recognition of tuberculosis symptoms
• Passive, facility-based case-finding
• The Xpert® MTB/RIF assay was available at the hospital, while the two decentralized facilities had only smear microscopy
People who initiated tuberculosis treatment in study facilities (0–14 years)
Malik et al., 201823 Pakistan; Jamshoro, a rural district, was the intervention area; Hyderabad, a neighbouring district with similar demographics, was the control area Pre-post study with control area People (all ages) with tuberculosis signs or symptoms attending outpatient departments of three general hospitals and one chest clinic • Screening in primary care settings performed by CHWs in general, paediatric and chest outpatient departments. People with symptoms or contact with tuberculosis patient were referred for evaluation
• Transport enablers were given to households of tuberculosis patients for bringing contacts to the health facility for screening
• Training of medical officers in childhood tuberculosis diagnosis and management
• Community awareness: advertisements on television and signboards
• No explicit description of the pre-intervention care model is given Tuberculosis cases notified in study districts (0–14 years)
Mathew et al., 200535 India; Palamu district in Jharkhand state, a poor district with a large tribal population Retrospective cohort study with concurrent comparator Patients (all ages) treated at Nav Jivan Hospital • Patients went to hospital once every 2 months
• Community DOT: a member of the community, not a family member, was recruited to keep medications and directly observe treatment
• Drugs were free
• Patients paid a 300-rupee deposit which would be refunded after completion of treatment
• Patients went to hospital monthly
• A family member was expected to supervise treatment
• Patients paid for drugs
• Patients paid a 300-rupee deposit which would be refunded after completion of treatment
Standard tuberculosis disease treatment outcomes (0–14 years)
Miyano et al., 201340 Zambia; Mumbwa district, rural Pre-post study with control facilities Unclear; outcome is tuberculosis patients (all ages) who enrolled in treatment, but how these patients were diagnosed and how they entered care is not discussed • Tuberculosis diagnostic and treatment services offered at decentralized rural health centres
• Co-location of ART: HIV diagnosis and ART available at rural health centres
• Tuberculosis diagnostic and treatment services offered at decentralized rural health centres (same as intervention)
• HIV diagnosis available at rural health centres, but ART only available at hospitals
People who initiated tuberculosis treatment in study facilities (0–14 years)
Moyo et al., 201231 South Africa; Cape Winelands District Randomized trial Healthy infants vaccinated with bacille Calmette–Guérin within 72 hours of birth were enrolled within 2 weeks of birth • Home visits for screening were made every 3 months by the study team. Children with a close tuberculosis contact or symptoms were evaluated at a study clinic
• Tuberculosis registers of study area clinics were monitored. If an adult tuberculosis patient was identified as a contact of a study participant or a participant was diagnosed with tuberculosis, the participant was evaluated at a study clinic
• Hospital admission and X-ray department records were reviewed to identify potential tuberculosis-related conditions. Participants with these conditions were evaluated at a study clinic
• No home visits
• Monitoring of tuberculosis registers, hospital admission records and X-ray department records was performed as for the intervention group
Tuberculosis cases diagnosed per person-years of follow-up (0–6, 6–12, 12–18, 18–26 months)
Oshi et al., 201624 Nigeria; Akwa Ibom, Rivers, Enugu, Ebonyi, Ogun and Lagos states; six control states chosen from the same geographical regions Pre-post study with control area Children/adolescents 0–14 years old with tuberculosis signs or symptoms attending 30 study health facilities and household contacts 0–14 years old of patients with smear-positive tuberculosis • Training on screening, diagnosis and management of childhood tuberculosis for medical officers, paediatricians, nurses and general health workers
• Training of medicine vendors on identification of presumptive child tuberculosis
• Screening in primary care settings (general and child outpatient clinics) and screening in ART clinics was performed by nurses, general health workers and dedicated screeners. Children with symptoms were referred for evaluation
• Home visits for contact screening were performed (but unclear by whom)
• Community awareness of childhood tuberculosis was promoted via handbills and posters and education in primary schools
• Supplies: tuberculin was procured and distributed
• No explicit description of the pre-intervention care model is given Tuberculosis cases notified in study districts (0–14 years)
Oxlade et al., 202144 Indonesia; Bandunga Cluster-randomized trial (cluster: health facilities) Household contacts of tuberculosis patients at seven intervention and eight control primary health clinics • Training on household contact identification, evaluation and latent tuberculosis infection diagnosis given once at the beginning and reinforced twice per month
• Educational flip charts and contact management register introduced into health facilities
• Periodic care cascade performance reviews
• Integrated database reminder system
• Toys given to children attending visits
• No intervention Contacts who initiated preventive treatment (0–4 years)
Reddy et al., 201532 India; Kolar and Bidar districts of Karnataka state Pre-post study with control area People (all ages) with tuberculosis signs or symptoms who belong to lower caste or tribal groups • Screening in homes and delivery of tuberculosis education was performed by trained community volunteers who visited homes of people belonging to vulnerable populations
• People with symptoms were either referred to health facilities or had sputum collected in the home
• Passive case-finding (no additional description) Smear-positive tuberculosis cases notified in study districts (0–14 years)
Rocha et al., 201143 Peru; eight contiguous shanty towns in northern Lima Pre-post study without control area Tuberculosis patients (all ages) and their household contacts (all ages); preventive treatment outcomes assessed for contacts 0–19 years old, who are eligible for preventive treatment in Peru • Psychosocial support activities included home visits, community mobilization workshops for groups of tuberculosis-affected households and psychological counselling
• Food support
• Economic support: cash transfers, microcredit loans, vocational training and microenterprise activities
• All interventions were offered to all households, but patients and household members could choose whether to accept individual components
• No explicit description of the pre-intervention care model is given Contacts who initiated preventive treatment among all contacts, contacts who completed preventive treatment (0–19 years)
Sachdeva et al., 201533 India; 18 subdistricts in diverse geographical and demographic settings Pre-post study without control area People (all ages) with tuberculosis signs or symptoms attending all 99 microscopy centres and their associated primary care facilities (3–5 per microscopy centre) in study subdistricts • People identified with tuberculosis symptoms in primary care facilities were referred to microscopy centres
• Two sputum samples were collected and tested by Xpert® MTB/RIF assay at that microscopy centre or another one in the same subdistrict (one Xpert® machine per subdistrict)
• People identified with tuberculosis symptoms in primary care facilities were referred to microscopy centres
• Two sputum samples collected for smear microscopy
• Unclear whether there was centralized Xpert® MTB/RIF assay capacity, but study is described as a decentralization of Xpert® MTB/RIF testing
Pulmonary tuberculosis cases diagnosed among people tested for tuberculosis in study subdistricts (0–14 years)
Szkwarko et al., 202145 Kenya; Bungoma county Pre-post study without control area Children 0–15 years old attending county hospital • Screening in hospital paediatric outpatient clinics (nutrition, maternal–child health, acute care) was conducted in waiting rooms by trained CHWs equipped with a mobile phone screening app
• Caregivers of children who screened positive were given a card that alerted the health-care worker to consider presumptive tuberculosis
• No screeners in waiting rooms of paediatric outpatient clinics People registered for tuberculosis treatment at hospital tuberculosis clinic (0–15 years)
Talukder et al., 201225 Bangladesh; 10 randomly selected districts where Damien Foundation was supporting microscopy centres Cluster-randomized trial (cluster: microscopy centres) Children and adolescents 0–14 years old attending 18 intervention microscopy and 18 control centres, including contacts and people with tuberculosis signs or symptoms • Training (2-day) in child tuberculosis screening and diagnosis for tuberculosis and Leprosy Control Assistants, their supervisors, government health centre doctors, field coordinators and field workers
• Supplies: microscopy centres were given flip charts for health education, scales and tuberculin
• Community awareness activities, including distributing posters and pamphlets and disseminating messages about childhood tuberculosis at various types of community meetings
• Introduction of a flowchart for screening and referral of children based on Keith Edwards Child Tuberculosis Score
• Training (2-day) in child tuberculosis screening and diagnosis for Leprosy Control Assistants and field coordinators, but not field workers or other cadres
• The absence of the other intervention components (supplies, community awareness activities, flowchart for screening and referral) is assumed but not stated
People diagnosed with tuberculosis at study microscopy centres (0–14 years)
Tripathy et al., 201336 India; Bangalore city Retrospective cohort study with concurrent comparator Patients (all ages) with new, smear-positive tuberculosis treated in public health services • Community DOT: patient received treatment from a community DOT provider, defined as a person who volunteered to administer DOT and who belonged to the community where the patient resided, but was not a government health worker or a member of the family • Patient received treatment from an institution DOT provider, defined as a government health worker at a health facility Patients with treatment success (0–14 years)
Wingfield et al., 201742 Peru; Callao shanty towns Cluster-randomized trial (cluster: households) Household contacts 0–19 years old of patients newly initiating tuberculosis treatment • Social support via household visits and community meetings to educate, empower and reduce stigma among patients and contacts
• Economic support: conditional cash transfers to defray hidden costs of being on treatment. Cash transfers were given for index patient adherence to tuberculosis, contacts being screened, contacts adhering to preventive treatment and engagement with social support activities
• No intervention Contacts who initiated preventive treatment among all contacts (0–19 years)
Yassin et al., 201338 Ethiopia; Sidama zone Pre-post study without control area Household contacts 0–4 years old are the population for which the extracted outcome is assessed; the target population of the intervention was much broader • Field supervisors screened household contacts of patients with smear-positive tuberculosis and initiated preventive treatment for asymptomatic children < 5 years old
• This study also included many other components aimed at using health extension workers to conduct tuberculosis screening and monitor tuberculosis patients in the community, increase microscopy capacity and raise community awareness. However, these were unlikely to affect the preventive treatment outcome
• Contact tracing and preventive treatment were recommended by the national tuberculosis programme but were not being implemented Contacts who initiated preventive treatment (0–4 years)
Zachariah et al., 200339 Malawi; Thyolo district, rural Pre-post study without control area Child contacts 0–5 years old of newly diagnosed patients with smear-positive tuberculosis being treated at the main public hospital in the district • Home visits for contact screening were performed. Children ≤ 5 years old were given referral slips for chest X-ray at the hospital. Preventive treatment could be initiated following evaluation
• Sputum collection in the home was performed for contacts with cough > 3 weeks
• Index patients were informed that any household contact with cough should come to the hospital for evaluation and any household contact aged ≤ 5 years old should come to the hospital for evaluation and preventive treatment initiation Contacts who initiated preventive treatment among all contacts (0–5 years)
Zawedde-Muyanja et al., 201826 Uganda; Kabarole (rural) and Wakiso (urban) districts Pre-post study without control area Children/adolescents 0–14 years old attending the 57 level III/IV health centres (larger health centres with laboratories) in the intervention districts, including contacts and people with tuberculosis signs or symptoms • Training delivered by health-care workers from district hospitals (level V) to health-care workers from level III/IV health centres on child tuberculosis diagnosis, treatment and prevention. They also provided on-site mentorship and supportive supervision monthly initially and then quarterly
• Training for health-care workers at level IV centres in sputum induction and gastric lavage; access to e-learning child tuberculosis course was given
• Training (2-day) for CHWs on symptom screening and contact management
• Home visits for contact screening and treatment support made by CHWs. Contacts referred for evaluation and preventive treatment
• Procurement support given and microscopes repaired to improve clinic and laboratory functionality
• No explicit description of the pre-intervention care model is given, but 96% of childhood tuberculosis cases in the pre-intervention period were diagnosed by referral hospitals as opposed to health centres. The intervention is framed as decentralization of capacity for childhood tuberculosis management, so we assume that diagnostic and treatment capacity for childhood tuberculosis was centralized at the hospitals before the intervention Tuberculosis cases notified in study districts, tuberculosis disease treatment outcomes (0–4, 0–14 years)

ART: antiretroviral therapy; CHW: community health worker; DOT: direct observed therapy; EGPAF: Elizabeth Glaser Pediatric AIDS Foundation; HIV: human immunodeficiency virus; SMS: short message service.

a Data from Indonesia included in this review. Other sites were not countries of interest (Benin and Canada) or their preventive treatment results did not separate child contacts and contacts of all ages with HIV (Benin, Ghana and Viet Nam).

Note: Standard tuberculosis disease treatment outcomes are treatment success (completion or cure), treatment failure, loss to follow-up and death.

Table 2. Characteristics of non-comparative studies of integrated or family-centred care included in the scoping review on tuberculosis care models for children and adolescents.

Study Country; setting Study design Population Intervention Outcome (age groups available for children or adolescents)
Demissie et al., 200355 Ethiopia; Este and Adet districts in Amhara state Retrospective cohort study Tuberculosis patients living in rural villages • Social support via establishment of tuberculosis clubs of patients living in the same area Standard tuberculosis disease treatment outcomes (0–14 years)
Dick et al., 199659 South Africa; Cape Flats suburb, Western Cape Retrospective cohort study Tuberculosis patients • Choice of treatment supporter to supervise DOT. Options included clinic staff and community volunteers
• Choice of treatment locations included work, school or a specialized childcare centre
Patients who took ≥ 75% of doses in 6 months (0–14 years)
Htet et al., 201853 Myanmar; Mandalay city Prospective cohort study Household contacts of tuberculosis patients receiving treatment for at least 3 months • Transportation was provided to contacts to take them to and from health facility
• Chest radiography was facilitated for all contacts
Tuberculosis cases diagnosed among contacts (0–14 years)
Kay et al., 202265 Eswatini; Hhohho Prospective cohort study Household members of pulmonary tuberculosis patients whose households included a child younger than 5 years • Choice of location for initial contact evaluation (facility or at home visit)
• Asymptomatic child contacts < 5 years old offered 3-month isoniazid rifampicin preventive treatment regimen
• Choice of location for preventive treatment management (facility or home-based)
Contacts who completed preventive treatment (0–4 years)
Imsanguan et al., 202054 Thailand; Chiang Rai province Prospective cohort study Household and non-household contacts of tuberculosis patients • Transport enablers provided to contacts for them to travel to a health facility for evaluation
• Vouchers for free chest radiography provided to contacts (normally chest radiographs are not free)
Tuberculosis cases diagnosed among contacts (0–4, 5–18 years)
Mandalakas et al., 202050 Botswana, Eswatini, Lesotho, Malawi, Uganda, United Republic of Tanzania; facilities affiliated with Baylor International Pediatric AIDS Initiative Retrospective cohort study Children and adolescents living with HIV who were receiving tuberculosis treatment • Children received tuberculosis and HIV treatment at HIV care centres Standard tuberculosis disease treatment outcomes (0–19 years)
Mehra et al., 201647 India; Delhi city Retrospective cohort study Clients diagnosed with HIV at an HIV counselling and testing centre • Screening of clients at HIV testing centre with referral of people with presumptive tuberculosis to tuberculosis clinic for evaluation Tuberculosis cases diagnosed among people screened (0–14 years)
Mesic et al., 202062 Afghanistan; Kandahar province Retrospective cohort study Patients with rifampicin-resistant tuberculosis • Transport enablers for patients, caretakers and contacts
• Accommodation provided for patients from outside Kandahar city
• Counselling by trained counsellors
• Social support via peer groups
• Patient preferences between individualized and short regimens were considered
Patients with treatment success (0–14 years)
Oyieng’o et al., 201256 Kenya; Western and North Rift provinces Retrospective cohort study Patients with MDR tuberculosis • Home-based treatment support provided by a nurse where available
• Transport enablers for patients
• Food supplementation and access to other social services provided
Patients with treatment success (15 years; only one non-adult patient)
Patel et al., 201351 Democratic Republic of the Congo; Kinshasa city Prospective cohort study Children and adolescents living with HIV who were receiving tuberculosis treatment • Tuberculosis and HIV treatment provided at primary health centres during the same clinic visits Standard tuberculosis disease treatment outcomes (3–18 years)
Qader et al., 201948 Afghanistan; Kabul, Jalalabad, Kandahar, Herat and Mazar-e-Sharif provinces Prospective cohort study Patients being treated for mental health conditions at one private and five public mental health centres • Symptom screening of patients registered in mental health centres conducted by nurses working in those centres
• Home-based screening or telephone-based screening for some patients
Tuberculosis cases diagnosed among people screened (0–15 years)
Reif et al., 201852 Haiti; Port-au-Prince city Retrospective cohort study Adolescents with microbiologically confirmed tuberculosis receiving care at an integrated tuberculosis and HIV clinic, most of whom were HIV-negative • Tuberculosis and HIV treatment provided at the same integrated adolescent care clinic
• Transport enablers
• Social support via HIV peer educators
• System of patient tracking established to contact patients who missed clinic appointments by phone or home visit
Standard tuberculosis disease treatment outcomes (10–15, 16–19 years)
Satti et al., 201257 Lesotho, national cohort Retrospective cohort study Children and adolescents with MDR tuberculosis • Community-based treatment support by trained and paid CHWs
• Both tuberculosis and HIV treatment delivered by the same CHWs for patients with both tuberculosis and HIV
• Transport enablers
• Nutritional supplements provided
• Economic support through helping families start income-generating activities
• Counselling and psychosocial support
• Assistance returning to school
Standard tuberculosis disease treatment outcomes (2–15 years)
Soomro et al., 201260 Pakistan, Rawalpindi district Retrospective cohort study Patients with smear-positive tuberculosis registered in the public sector • Choice of treatment supporter: options were health facility staff, CHWs, community volunteers, lady health workers and family members Patients with treatment success (0–14 years)
Szkwarko et al., 201649 Kenya, Eldoret city Prospective cohort study Street-connected young people • Screening and sputum collection in congregate settings where street-connected young people sleep
• Screening and sputum collection in centres providing services for street-connected young people by a symptom screener from the tuberculosis programme working with the centre’s medical outreach worker
• Tuberculosis education provided at places where street-connected young people stay
Tuberculosis cases diagnosed among people screened (10–18 years)
Triasih et al., 201664 Indonesia; Yogyakarta city Prospective cohort study Child contacts of tuberculosis patients • Choice of location for preventive treatment: options were a primary health centre, lung clinic or hospital Contacts who initiated preventive treatment among eligible contacts, contacts who completed preventive treatment (0–4 years)
van den Boogaard et al., 200961 United Republic of Tanzania; Kilimanjaro region Retrospective cohort study Tuberculosis patients • Choice of location for DOT: options were facility-based or community-based DOT Patients with treatment success (0–14 years)
Wai et al., 201758 Myanmar; 33 townships Retrospective cohort study Patients with MDR tuberculosis • Home-based treatment support by a trained and paid community volunteer, who helps patient access treatment and coordinates specimen transport
• Economic support through monthly cash transfer to offset expenses of lodging when visiting tuberculosis care centres and ancillary drugs
• Food support
• Counselling for patient, family and neighbours
• Community awareness promoted by providing health education to patient, family and neighbours
Patients with treatment success (0–14 years)
Yuen et al., 201963 Peru; Carabayllo district of Lima city Prospective cohort study Contacts of tuberculosis patients • Home visits to encourage household contacts to complete evaluation
• Home-based preventive treatment support with adherence counselling by a CHW and monthly visits by a nurse technician for adverse event monitoring
• Transport enablers
• Assistance coordinating monthly appointments
Contacts who initiated preventive treatment among all contacts, contacts who completed preventive treatment (0–19 years)

CHW: community health worker; DOT: direct observed therapy; HIV: human immunodeficiency virus; MDR: multidrug-resistant.

Note: Standard tuberculosis disease treatment outcomes are treatment success (completion or cure), treatment failure, loss to follow-up and death.

Evidence synthesis

Decentralized care interventions

Of the 23 studies assessing the impact of a decentralized care model (Table 3),1939,44,46 our thematic analysis identified two major intervention approaches: strengthening services within health facilities and providing services in communities (Fig. 2). Facility-based approaches included training primary-level providers in diagnosing and/or managing children with tuberculosis, lay-workers performing symptom screening in facilities, engaging private sector primary-level providers and making treatment services available in a more decentralized type of health facility. Community-based approaches included home visits for contact screening and community-based treatment support. Some interventions included both facility-based and community-based activities, while others included only one or the other. In addition, nine interventions included community awareness campaigns or health system strengthening through provision of supplies or procurement support to health facilities; these activities did not clearly fall into one of the care models of interest but could have contributed to improved outcomes. Most interventions received support from international funders and introduced dedicated personnel or resources into the health system.

Table 3. Evidence for impact of decentralized care on child and adolescent tuberculosis diagnosis, treatment and prevention outcomes.
Type of outcome, care delivery approach Study Intervention condition outcomes Control condition outcomes Effect estimate
(95% CI)
Diagnosis
Strengthen services in facilities and provide services or outreach in communities EGPAF, 201846 5865 cases in 20.6 months 2295 cases in 12 months IRR: 1.49 (1.42–1.56)
Islam et al., 201719 231 cases in 24 months 65 cases in 12 months IRR: 1.78 (1.35–2.34)
Joshi et al., 201520 360 cases in 12 months 113 cases in 12 months IRR: 1.14 (0.83–1.56)a
Khan et al., 201221 205 cases in 12 months 28 cases in 12 months IRR: 7.32 (4.39–10.87)
Maha et al., 201922 295 cases in 24 months 140 cases in 24 months IRR: 2.11 (1.72–2.58)
Malik et al., 201823 1391 cases in 36 months 417 cases in 18 months IRR: 2.96 (2.49–3.50)a
Oshi et al., 201624 1590 cases in 12 months 1210 cases in 12 months IRR: 1.31 (1.22–1.42)
Talukder et al., 201225 175 cases in 24 months 130 cases in 24 months IRR: 1.87 (1.28–2.71)
Zawedde-Muyanja et al., 201826 657 cases in 12 months 271 cases in 12 months IRR: 2.39 (2.07–2.75)
Services in communities Hanrahan et al., 201927 189 cases in 18 months 216 cases in 18 months IRR: 0.88 (0.31–2.46)
Bayona et al., 200328 1/151 (1%) contacts diagnosed with tuberculosis 3/118 (3%) contacts diagnosed with tuberculosis RR: 0.26 (0.01–2.56)
Fatima et al., 201629 13 288 cases in 24 months 12 506 cases in 24 months IRR: 1.06 (1.03–1.08)
Davis et al., 201930 8/216 (4%) contacts diagnosed with tuberculosis 10/227 (4%) contacts diagnosed with tuberculosis RR: 0.84 (0.34–2.09)
Moyo et al., 201231 89/2381 (4%) children diagnosed with tuberculosis 36/2382 (2%) children diagnosed with tuberculosis Ratio of event rate per person-year: 2.6 (1.8–4.0)b
Reddy et al., 201532 7 cases in 6 months 2 cases in 6 months IRR: 0.71 (0.04–12.07)a
Strengthen services in facilities Sachdeva et al., 201533 271/2570 (11%) evaluated individuals diagnosed with tuberculosis 46/428 (11%) evaluated individuals diagnosed with tuberculosis RR: 0.98 (0.72–1.33)
Treatment
Strengthen services in facilities and provide services in communities Zawedde-Muyanja et al., 201826 310/382 (81%) patients with treatment success 121/186 (65%) patients with treatment success RR: 1.25 (1.11–1.40)
Services in communities Jeena & Naidoo, 201634 65/82 (79%) patients with treatment success 52/97 (54%) patients with treatment success RR: 1.48 (1.19–1.84)
Mathew et al., 200535 16/16 (100%) patients with treatment success 31/45 (69%) patients with treatment success RR: 1.45 (1.19–1.77)
Tripathy et al., 201336 7/7 (100%) patients with treatment success 22/23 (96%) patients with treatment success RR: 1.05 (0.96–1.14)
Strengthen services in facilities Datiko & Lindtjørn, 200937 21/23 (91%) patients with treatment success 8/9 (89%) patients with treatment success RR: 1.03 (0.79–1.34)
Prevention
Strengthen services in facilities and provide services in communities EGPAF, 201846 12 634 preventive treatment initiations in 20.6 months 1758 preventive treatment initiations in 12 months 8-fold increase in median monthly preventive treatment initiations per site, P < 0.001b
Yassin et al., 201338 698 preventive treatment initiations in 6 months 0 preventive treatment initiations in 15 months Undefined
Services in communities Zachariah et al., 200339 25/113 (22%) identified contacts initiated preventive treatment 22/126 (17%) identified contacts initiated preventive treatment RR: 1.27 (0.76–2.12)
Strengthen services in facilities Oxlade et al., 202144 12 preventive treatment initiations in 6 months 3 preventive treatment initiations in 6 months IRR: 4.00 (1.08–22.09)

CI: confidence interval; EGPAF: Elizabeth Glaser Pediatric AIDS Foundation; IRR: incidence rate ratio; RR: risk ratio.

Note: We defined children and adolescents as people 0–19 years old, but individual studies focused on different age groups within this range.

a Rate ratio adjusted for change in case notifications in a control area during the same time period.

b This effect estimate reported by the study was more rigorous than what we could derive from available count data.

Fig. 2.

Tuberculosis care delivery approaches for children and adolescents

HIV: human immunodeficiency virus.

Note: Based on the 47 included studies.

Fig. 2

Grouping studies by outcome and whether they contained facility-based service strengthening, community-based services or both yielded nine groups of studies of decentralized care (Table 3). The largest group comprised nine studies that simultaneously used facility-based interventions to improve the quality of diagnostic services in primary-level settings and community-based interventions to increase the likelihood that children or adolescents with tuberculosis would enter the health system.1926,46 This combined facility and community approach consistently increased tuberculosis diagnoses in the 0–14 years age group, with effect sizes ranging from a one-to-sevenfold increase in diagnoses. In contrast, tuberculosis diagnoses did not generally increase in studies of interventions that screened people in their homes but referred them to existing health services for evaluation.2732 We also observed this contrast among three tuberculosis preventive treatment studies. Large increases in preventive treatment initiation were achieved in the studies that simultaneously strengthened preventive treatment services in health facilities and provided home-based screening for contacts,38,46 but not in the study that used home-based screening alone.39 Improved treatment outcomes in the 0–14 year age group were observed for studies that included community-based treatment support, with at least 79% of patients in the intervention groups achieving treatment success.26,3436 Five studies disaggregated results for young children versus older children and adolescents, but there was no clear consensus about whether interventions benefited these groups differentially based on the data presented (results available in the data repository).16,20,26,27,30,34

Integrated care interventions

We identified three comparative studies where integration was the primary intervention (Table 4).40,41,45 A stepped-wedge trial in Ethiopia showed that screening in integrated maternal, neonatal and child illnesses clinics increased tuberculosis diagnoses among children (0.5; 95% CI: 0.2–0.7; additional cases per clinic per 4-month period).41 A pre-post study from Zambia showed that having antiretroviral services and tuberculosis services in the same health facilities led to increased case notifications in the 0–14 year age group (IRR: 2.67; 95% CI: 1.05–6.76).40 A pre-post study from Kenya showed that screening in the maternal–child health, nutrition and acute care departments of a hospital did not significantly increase tuberculosis treatment registrations in the 0–14 year age group (IRR: 0.88; 95% CI: 0.44–1.77).45

Table 4. Evidence for impact of integrated care on child and adolescent tuberculosis diagnosis and treatment outcomes.
Type of outcome, care delivery approach Study Intervention condition outcomes Control condition outcomes Effect estimate
(95% CI)
Diagnosis
Introducing ART services into health centres with tuberculosis services Miyano et al., 201340 40 tuberculosis patients registered during 3 intervention years (13 per year) 5 tuberculosis patients registered in pre-intervention year IRR: 2.67 (1.05–6.76)
Tuberculosis screening in clinic or centre providing care for another condition Ketema et al., 202041 38/95 618 (4 per 10 000) children attending Integrated maternal, neonatal and child illnesses clinics were diagnosed with tuberculosis 9/85 278 (1 per 10 000) children attending integrated maternal, neonatal and child illnesses clinics were diagnosed with tuberculosis 0.5: (0.2–0.7) additional cases per clinic per 4-month perioda
Szkwarko et al., 202145 15 tuberculosis patients registered after introducing screening programme in maternal and child health nutrition and acute care clinics 17 tuberculosis patients registered in pre-intervention period IRR: 0.88 (0.44–1.77)
Joshi et al., 201520 0/700 (0%) children attending maternal–child health clinics diagnosed with tuberculosis NR NR
Oshi et al., 201624 133/2686 (5%) HIV clinic attendees diagnosed with tuberculosis NR NR
Mehra et al., 201647 0/6 (0%) HIV clinic attendees diagnosed with tuberculosis NA NA
Qader et al., 201948 4/467 (1%) mental health centre clients diagnosed with tuberculosis NA NA
Szkwarko et al., 201649 0/53 (0%) street-connected young people diagnosed with tuberculosis NA NA
Treatment
Tuberculosis treatment and ART provided at the same clinic Mandalakas et al., 202050 857/1160 (74%) patients with treatment success NA NA
Patel et al., 201351 27/31 (87%) patients with treatment success NA NA
Reif et al., 201852 277/345 (80%) patients with treatment success NA NA

ART: antiretroviral therapy; CI: confidence interval; HIV: human immunodeficiency virus; IRR: incidence rate ratio; NA: not applicable; NR: not reported.

a This effect estimate reported by the study was more rigorous than what we could derive from available count data.

Note: We defined children and adolescents as people 0–19 years old, but individual studies focused on different age groups within this range.

Among both comparative and non-comparative studies, integrated approaches to care included tuberculosis screening in clinics or centres for other health conditions and co-location of tuberculosis and HIV treatment (Fig. 2). Tuberculosis screening was performed in HIV clinics, maternal–child health clinics, nutrition clinics, mental health centres and a centre providing services to street-connected young people. In general, the proportion of screened children diagnosed with tuberculosis in integrated interventions was small, except for screening conducted in an HIV clinic.24 Three non-comparative studies described delivering both tuberculosis treatment and antiretroviral therapy in a single clinic to children and adolescents living with HIV;5052 the proportion with successful treatment in these studies ranged from 74% to 87%.

Family-centred care interventions

We identified two comparative studies where family-centred care was the primary intervention (Table 5). A cluster-randomized trial from Peru showed that providing socioeconomic support to families affected by tuberculosis increased the proportion of contacts aged 0–19 years who initiated preventive treatment (RR: 1.70; 95% CI: 1.10–2.64).42 An earlier pre-post study from the same setting showed that socioeconomic support improved both preventive treatment initiation (RR: 2.23; 95% CI: 2.11–2.36) and preventive treatment completion (RR: 3.22; 95% CI: 2.90–3.57).43 Among both comparative and non-comparative studies, family-centred approaches fell into two main categories: support for patients and families; and patient choice (Fig. 2). Support strategies included transport enablers to help people get to health facilities, food or nutritional supplements, cash transfers, support for income-generating activities, psychological counselling and establishing peer groups of people affected by tuberculosis to promote mutual support and empowerment. Patient choice strategies included considering patient preferences for treatment supporter, location and regimen. Five studies that provided socioeconomic or psychosocial support during treatment reported treatment success among at least 71% of children and adolescents with tuberculosis.5558,62

Table 5. Evidence for impact of family-centred care on child and adolescent tuberculosis diagnosis, treatment and prevention outcomes.
Type of outcome, care delivery approach Author Intervention condition outcomes Control condition outcomes Effect estimate
(95% Cl)
Diagnosis
Support Htet et al., 201853 10/59 (17%) contacts diagnosed with tuberculosis NA NA
Imsanguan., et al., 202054 3/48 (6%) contacts diagnosed with tuberculosis NA NA
Choice Kay et al., 202265 3/492 (1%) contacts diagnosed with tuberculosis NA NA
Treatment
Support Demissie et al., 200355 5/7 (71%) patients with treatment success NA NA
Oyieng’o et al., 201256 1/1 (100%) MDR-tuberculosis patient with treatment success NA NA
Satti et al., 201257 15/17 (88%) MDR-tuberculosis patients with treatment success NA NA
Wai et al., 201758 1/1 (100%) MDR-tuberculosis patient with treatment success NA NA
Choice Dick et al., 199659 148/203 (73%) patients classified as adherent NA NA
Soomro et al., 201260 14/14 (100%) patients with treatment success NA NA
van den Boogaard et al., 200961 245/308 (80%) patients with treatment success NA NA
Support and choice Mesic et al., 202062 8/11 (73%) patients with rifampicin-resistant tuberculosis with treatment success NA NA
Prevention
Support Wingfield et al., 201742 91/206 (44%) identified contacts initiated preventive treatment 53/206 (26%) identified contacts initiated preventive treatment RR: 1.70 (1.10–2.64)
Rocha et al., 201143 477/542 (88%) identified contacts initiated preventive treatment 1116/2929 (39%) identified contacts initiated preventive treatment RR: 2.23 (2.11–2.36)
383/441 (87%) contacts completed preventive treatment 301/1116 (27%) contacts completed preventive treatment RR: 3.22 (2.90–3.57)
Yuen et al., 201963 57/140 (41%) identified contacts initiated preventive treatment NA NA
51/57 (89%) contacts completed preventive treatment NA NA
Choice Triasih et al., 201664 86/99 (87%) eligible contacts initiated preventive treatment NA NA
50/86 (58%) contacts completed preventive treatment NA NA
Kay et al., 202265 237/248 (96%) contacts completed preventive treatment NA NA

CI: confidence interval; MDR: multidrug resistant; NA: not applicable; RR: risk ratio.

Note: We defined children and adolescents as people 0–19 years old, but individual studies focused on different age groups within this range.

Evidence gaps

We found limited reports assessing the impact of integrated and family-centred care models on children and adolescents affected by tuberculosis, although non-comparative studies suggest that programmes are providing integrated and family-centred care to children and adolescents. Many studies that may have included children and adolescents did not sufficiently age-disaggregate data to allow assessment of child and adolescent outcomes. Even where data were age-disaggregated, the conventional use of 0–14 years as the youngest age group meant that we were unable to separate child from adolescent outcomes, and outcomes for older adolescents were generally aggregated with an adult age group.

Discussion

Our review identified a large variety of decentralized, integrated and family-centred care approaches for children and adolescents with tuberculosis disease and exposure. We found substantial evidence that simultaneously strengthening diagnostic services in decentralized health facilities and strengthening the linkages between communities and these facilities improves case detection, but doing only one or the other does not. More limited evidence suggests that strengthening decentralized preventive treatment services and providing socioeconomic support to families improves preventive treatment initiation and completion. Consistent with a previous review,5 we found that community-based treatment support improves tuberculosis disease treatment outcomes. Finally, integrated and family-centred approaches are being used by programmes in diverse settings and are achieving good outcomes, despite a dearth of formal impact evaluations of these approaches.

Our findings highlight a couple of key considerations for the design of care models that improve child and adolescent tuberculosis outcomes. One consideration is the importance of reducing barriers simultaneously in the community and in facilities. Doing only one or the other may in some instances improve tuberculosis case detection among adults but not children, given that adults can more readily be diagnosed by sputum testing.29,33 However, reducing barriers in communities and facilities for the benefit of children and adolescents may benefit adults as well.66 Another consideration is the importance of introducing new resources or workers to improve child and adolescent tuberculosis care. Funding is required to pay dedicated staff, provide transport enablers for community health workers or patients, provide supplies or equipment to health facilities or provide material support to patients and their families. When funding for these services becomes unavailable, programmatic gains may be lost.67 If health system strengthening is incorporated into an intervention strategy, then positive impact may be maintained even after a time-limited activity (e.g. a mass community screening effort) ends.68

Our review also identified two key priority areas for future research. One area is identifying effective integrated or family-centred care approaches for children and adolescents. Ongoing studies are evaluating the integration of tuberculosis services with child health care services69 and shared decision-making for preventive treatment delivery location.70 Another potential approach that could be evaluated is providing coordinated care to an entire family through shared medical appointments or counselling sessions, which could be particularly useful in the context of expanding preventive treatment to contacts of all ages. A second area is care models for adolescents. Adolescents have unique health needs that require youth-centred strategies, particularly for diseases requiring prolonged or long-term treatment.71 Adolescent-centred strategies are being increasingly studied in the HIV field.72,73 However, tuberculosis services have generally not yet been tailored to adolescent needs,74,75 and our review identified only two studies that provided adolescent-centred services.49,52

A major limitation of our review is that the lack of clear definitions for the care models of interest made development of search terms challenging. However, strengths of our approach were the iterative process used to identify relevant literature, developed in consultation with people who work in tuberculosis programmes in countries with high tuberculosis burdens and the extensive use of existing systematic reviews. Even so, it is possible that we missed studies that described the care models of interest in ways that we did not consider. Another limitation is that we did not contact authors following article identification to request age-disaggregated data given time constraints, as we had a firm deadline aligned to the inputs into the WHO consolidated guidelines on the management of tuberculosis in children and adolescents.76 Authors of a previous systematic review of adherence support interventions for tuberculosis disease treatment in children did contact authors and consequently were able to compile a more comprehensive evidence base for this specific set of interventions.5 Finally, we limited our review to studies from countries with high prevalence of tuberculosis in an effort to identify the most relevant interventions for these settings. However, in doing so, we likely missed studies from countries that might have had more resources to conduct research around care delivery and where tuberculosis preventive treatment for adolescents is more common.

Our findings suggest that local and international policy-makers and funders should invest in decentralized, integrated and family-centred tuberculosis services to close the large case detection and prevention gaps for children and adolescents. Policies for decentralization should articulate strategies to strengthen services in both primary-level health facilities and communities, thereby promoting linkages to tuberculosis care. Module 5 in WHO operational handbook on tuberculosis provides practical guidance for programmes seeking to implement the approaches summarized in this review.77 Future research should focus on identifying which approaches to integrated and family-centred care for children and adolescents are effective in different settings and health systems and evaluating the impact of these approaches. When programmes identify successful approaches, decision-makers must provide resources to ensure large-scale uptake and sustainability.

Acknowledgements

Co-authors Yael Hirsch-Moverman and Hamidah Hussain contributed equally to the work. We thank Kausar Khan, Enos Masini, Marco Tovar, Benjamin Sweigart and Tim Nichols.

Funding:

This review was supported by a grant from the WHO Global Tuberculosis Programme related to the updating of the WHO consolidated guidelines on the management of tuberculosis in children and adolescents.76 MMD is supported by T32 AI007433 from the National Institute of Allergy and Infectious Diseases.

Competing interests:

AB, SV and KV are employees of WHO, which funded this work; TM is a WHO consultant. CMY, DS and HH are authors of studies included in the review. CMY, DS, HH and YHM have received research grants for studies involving decentralized, integrated or family-centred care. All other authors declare no competing interests.

References

  • 1.Global tuberculosis report 2021. Geneva: World Health Organization; 2021. Available from: https://www.who.int/publications/i/item/9789240037021 [cited 2022 Sep 28].
  • 2.Snow KJ, Sismanidis C, Denholm J, Sawyer SM, Graham SM. The incidence of tuberculosis among adolescents and young adults: a global estimate. Eur Respir J. 2018. Feb 21;51(2):1702352. 10.1183/13993003.02352-2017 [DOI] [PubMed] [Google Scholar]
  • 3.Perez-Velez CM, Marais BJ. Tuberculosis in children. N Engl J Med. 2012. Jul 26;367(4):348–61. 10.1056/NEJMra1008049 [DOI] [PubMed] [Google Scholar]
  • 4.Roadmap toward ending TB in children and adolescents. 2nd ed. Geneva: World Health Organization; 2018. Available from: https://apps.who.int/iris/handle/10665/275422 [cited 2022 Sep 28].
  • 5.Weaver MS, Lönnroth K, Howard SC, Roter DL, Lam CG. Interventions to improve adherence to treatment for paediatric tuberculosis in low- and middle-income countries: a systematic review and meta-analysis. Bull World Health Organ. 2015. Oct 1;93(10):700–711B. 10.2471/BLT.14.147231 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Burke RM, Nliwasa M, Feasey HRA, Chaisson LH, Golub JE, Naufal F, et al. Community-based active case-finding interventions for tuberculosis: a systematic review. Lancet Public Health. 2021. May;6(5):e283–99. 10.1016/S2468-2667(21)00033-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Mhimbira FA, Cuevas LE, Dacombe R, Mkopi A, Sinclair D. Interventions to increase tuberculosis case detection at primary healthcare or community-level services. Cochrane Database Syst Rev. 2017. Nov 28;11(11):CD011432. 10.1002/14651858.CD011432.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ho J, Byrne AL, Linh NN, Jaramillo E, Fox GJ. Decentralized care for multidrug-resistant tuberculosis: a systematic review and meta-analysis. Bull World Health Organ. 2017. Aug 1;95(8):584–93. 10.2471/BLT.17.193375 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Zhang H, Ehiri J, Yang H, Tang S, Li Y. Impact of community-based DOT on tuberculosis treatment outcomes: a systematic review and meta-analysis. PLoS One. 2016. Feb 5;11(2):e0147744. 10.1371/journal.pone.0147744 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Legido-Quigley H, Montgomery CM, Khan P, Atun R, Fakoya A, Getahun H, et al. Integrating tuberculosis and HIV services in low- and middle-income countries: a systematic review. Trop Med Int Health. 2013. Feb;18(2):199–211. 10.1111/tmi.12029 [DOI] [PubMed] [Google Scholar]
  • 11.Uyei J, Coetzee D, Macinko J, Guttmacher S. Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa: a systematic review. Lancet Infect Dis. 2011. Nov;11(11):855–67. 10.1016/S1473-3099(11)70145-1 [DOI] [PubMed] [Google Scholar]
  • 12.Richterman A, Steer-Massaro J, Jarolimova J, Luong Nguyen LB, Werdenberg J, Ivers LC. Cash interventions to improve clinical outcomes for pulmonary tuberculosis: systematic review and meta-analysis. Bull World Health Organ. 2018. Jul 1;96(7):471–83. 10.2471/BLT.18.208959 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Wen S, Yin J, Sun Q. Impacts of social support on the treatment outcomes of drug-resistant tuberculosis: a systematic review and meta-analysis. BMJ Open. 2020. Oct 8;10(10):e036985. 10.1136/bmjopen-2020-036985 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.van Hoorn R, Jaramillo E, Collins D, Gebhard A, van den Hof S. The effects of psycho-emotional and socio-economic support for tuberculosis patients on treatment adherence and treatment outcomes - a systematic review and meta-analysis. PLoS One. 2016. Apr 28;11(4):e0154095. 10.1371/journal.pone.0154095 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018. Nov 19;18(1):143. 10.1186/s12874-018-0611-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Yuen C. (2022): Appendix TB care models.pdf. figshare. Online resource. 10.6084/m9.figshare.21341898.v1 [DOI]
  • 17.Global tuberculosis report 2020. Geneva: World Health Organization; 2020. Available from: https://www.who.int/publications/i/item/9789240013131 [cited 2022 Sep 28].
  • 18.Use of high burden country lists for TB by WHO in the post-2015 era. Geneva: World Health Organization; 2015. [Google Scholar]
  • 19.Islam Z, Sanin KI, Ahmed T. Improving case detection of tuberculosis among children in Bangladesh: lessons learned through an implementation research. BMC Public Health. 2017. Jan 28;17(1):131. 10.1186/s12889-017-4062-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Joshi B, Chinnakali P, Shrestha A, Das M, Kumar AM, Pant R, et al. Impact of intensified case-finding strategies on childhood TB case registration in Nepal. Public Health Action. 2015. Jun 21;5(2):93–8. 10.5588/pha.15.0004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Khan AJ, Khowaja S, Khan FS, Qazi F, Lotia I, Habib A, et al. Engaging the private sector to increase tuberculosis case detection: an impact evaluation study. Lancet Infect Dis. 2012. Aug;12(8):608–16. 10.1016/S1473-3099(12)70116-0 [DOI] [PubMed] [Google Scholar]
  • 22.Maha A, Majumdar SS, Main S, Phillip W, Witari K, Schulz J, et al. The effects of decentralisation of tuberculosis services in the East New Britain Province, Papua New Guinea. Public Health Action. 2019. Sep 21;9 Suppl 1:S43–9. 10.5588/pha.18.0070 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Malik AA, Amanullah F, Codlin AJ, Siddiqui S, Jaswal M, Ahmed JF, et al. Improving childhood tuberculosis detection and treatment through facility-based screening in rural Pakistan. Int J Tuberc Lung Dis. 2018. Aug 1;22(8):851–7. 10.5588/ijtld.17.0736 [DOI] [PubMed] [Google Scholar]
  • 24.Oshi DC, Chukwu JN, Nwafor CC, Meka AO, Madichie NO, Ogbudebe CL, et al. Does intensified case finding increase tuberculosis case notification among children in resource-poor settings? A report from Nigeria. Int J Mycobacteriol. 2016. Mar;5(1):44–50. 10.1016/j.ijmyco.2015.10.007 [DOI] [PubMed] [Google Scholar]
  • 25.Talukder K, Salim MA, Jerin I, Sharmin F, Talukder MQ, Marais BJ, et al. Intervention to increase detection of childhood tuberculosis in Bangladesh. Int J Tuberc Lung Dis. 2012. Jan;16(1):70–5. 10.5588/ijtld.11.0060 [DOI] [PubMed] [Google Scholar]
  • 26.Zawedde-Muyanja S, Nakanwagi A, Dongo JP, Sekadde MP, Nyinoburyo R, Ssentongo G, et al. Decentralisation of child tuberculosis services increases case finding and uptake of preventive therapy in Uganda. Int J Tuberc Lung Dis. 2018. Nov 1;22(11):1314–21. 10.5588/ijtld.18.0025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Hanrahan CF, Nonyane BAS, Mmolawa L, West NS, Siwelana T, Lebina L, et al. Contact tracing versus facility-based screening for active TB case finding in rural South Africa: a pragmatic cluster-randomized trial (Kharitode TB). PLoS Med. 2019. Apr 30;16(4):e1002796. 10.1371/journal.pmed.1002796 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Bayona J, Chavez-Pachas AM, Palacios E, Llaro K, Sapag R, Becerra MC. Contact investigations as a means of detection and timely treatment of persons with infectious multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2003. Dec;7(12) Suppl 3:S501–9. [PubMed] [Google Scholar]
  • 29.Fatima R, Qadeer E, Yaqoob A, Haq MU, Majumdar SS, Shewade HD, et al. Extending ‘contact tracing’ into the community within a 50-metre radius of an index tuberculosis patient using Xpert MTB/RIF in urban Pakistan: did it increase case detection? PLoS One. 2016. Nov 29;11(11):e0165813. 10.1371/journal.pone.0165813 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Davis JL, Turimumahoro P, Meyer AJ, Ayakaka I, Ochom E, Ggita J, et al. Home-based tuberculosis contact investigation in Uganda: a household randomised trial. ERJ Open Res. 2019. Jul 29;5(3):00112-2019. 10.1183/23120541.00112-2019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Moyo S, Verver S, Hawkridge A, Geiter L, Hatherill M, Workman L, et al. ; South African Tuberculosis Vaccine Initiative Neonatal Study Team. Tuberculosis case finding for vaccine trials in young children in high-incidence settings: a randomised trial. Int J Tuberc Lung Dis. 2012. Feb;16(2):185–91. 10.5588/ijtld.11.0348 [DOI] [PubMed] [Google Scholar]
  • 32.Reddy KK, Ananthakrishnan R, Jacob AG, Das M, Isaakidis P, Kumar AM. Intensified tuberculosis case finding amongst vulnerable communities in southern India. Public Health Action. 2015. Dec 21;5(4):246–8. 10.5588/pha.15.0048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Sachdeva KS, Raizada N, Sreenivas A, Van’t Hoog AH, van den Hof S, Dewan PK, et al. Use of Xpert MTB/RIF in decentralized public health settings and its effect on pulmonary TB and DR-TB case finding in India. PLoS One. 2015. May 21;10(5):e0126065. 10.1371/journal.pone.0126065 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Jeena L, Naidoo K. Tuberculosis treatment outcomes among peri-urban children receiving doorstep tuberculosis care. Int J Tuberc Lung Dis. 2016. Feb;20(2):235–9. 10.5588/ijtld.15.0090 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Mathew A, Binks C, Kuruvilla J, Davies PD. A comparison of two methods of undertaking directly observed therapy in a rural Indian setting. Int J Tuberc Lung Dis. 2005. Jan;9(1):69–74. [PubMed] [Google Scholar]
  • 36.Tripathy SK, Kumar P, Sagili KD, Enarson DA. Effectiveness of a community-based observation of anti-tuberculosis treatment in Bangalore City, India, 2010-2011. Public Health Action. 2013. Sep 21;3(3):230–4. 10.5588/pha.13.0043 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Datiko DG, Lindtjørn B. Health extension workers improve tuberculosis case detection and treatment success in southern Ethiopia: a community randomized trial. PLoS One. 2009;4(5):e5443. 10.1371/journal.pone.0005443 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Yassin MA, Datiko DG, Tulloch O, Markos P, Aschalew M, Shargie EB, et al. Innovative community-based approaches doubled tuberculosis case notification and improve treatment outcome in Southern Ethiopia. PLoS One. 2013. May 27;8(5):e63174. 10.1371/journal.pone.0063174 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Zachariah R, Spielmann MP, Harries AD, Gomani P, Graham SM, Bakali E, et al. Passive versus active tuberculosis case finding and isoniazid preventive therapy among household contacts in a rural district of Malawi. Int J Tuberc Lung Dis. 2003. Nov;7(11):1033–9. [PubMed] [Google Scholar]
  • 40.Miyano S, Dube C, Kayama N, Ishikawa N, Nozaki I, Syakantu G. Association between tuberculosis treatment outcomes and the mobile antiretroviral therapy programme in Zambia. Int J Tuberc Lung Dis. 2013. Apr;17(4):540–5. 10.5588/ijtld.12.0432 [DOI] [PubMed] [Google Scholar]
  • 41.Ketema L, Dememew ZG, Assefa D, Gudina T, Kassa A, Letta T, et al. Evaluating the integration of tuberculosis screening and contact investigation in tuberculosis clinics in Ethiopia: a mixed method study. PLoS One. 2020. Nov 19;15(11):e0241977. 10.1371/journal.pone.0241977 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Wingfield T, Tovar MA, Huff D, Boccia D, Montoya R, Ramos E, et al. A randomized controlled study of socioeconomic support to enhance tuberculosis prevention and treatment, Peru. Bull World Health Organ. 2017. Apr 1;95(4):270–80. 10.2471/BLT.16.170167 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Rocha C, Montoya R, Zevallos K, Curatola A, Ynga W, Franco J, et al. The Innovative Socio-economic Interventions Against Tuberculosis (ISIAT) project: an operational assessment. Int J Tuberc Lung Dis. 2011. Jun;15(6) Suppl 2:50–7. 10.5588/ijtld.10.0447 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Oxlade O, Benedetti A, Adjobimey M, Alsdurf H, Anagonou S, Cook VJ, et al. Effectiveness and cost-effectiveness of a health systems intervention for latent tuberculosis infection management (ACT4): a cluster-randomised trial. Lancet Public Health. 2021. May;6(5):e272–82. 10.1016/S2468-2667(20)30261-9 [DOI] [PubMed] [Google Scholar]
  • 45.Szkwarko D, Amisi JA, Peterson D, Burudi S, Angala P, Carter EJ. Using a mobile application to improve pediatric presumptive TB identification in western Kenya. Int J Tuberc Lung Dis. 2021. Jun 1;25(6):468–74. 10.5588/ijtld.20.0890 [DOI] [PubMed] [Google Scholar]
  • 46.Catalyzing pediatric tuberculosis innovations (CaP TB): implementation and integration of new TB care and treatment models. Washington, DC: Elizabeth Glaser Pediatric AIDS Foundation; 2018. Available from: https://www.pedaids.org/wp-content/uploads/2018/04/Unitaid_CaPTB-FactSheet_12.18.18.pdf [cited 2022 Sep 28].
  • 47.Mehra B, Matlani M, Rawat D, Gautam H, Bhalla P. HIV-TB Cross-referral and collaborative strategy: 8 years of our experience from an urban health centre in north India. Indian J Chest Dis Allied Sci. 2016. Jan-Mar;58(1):11–6. [PubMed] [Google Scholar]
  • 48.Qader G, Seddiq MK, Rashidi KM, Hamim A, Akhgar MH, Ahmad B, et al. Prevalence of tuberculosis among mentally ill patients in conflict-stricken Afghanistan: a cross-sectional study. Int J Infect Dis. 2019. Dec;89:45–50. 10.1016/j.ijid.2019.08.020 [DOI] [PubMed] [Google Scholar]
  • 49.Szkwarko D, Mercer T, Kimani S, Braitstein P, Buziba N, Carter EJ. Implementing intensified tuberculosis case-finding among street-connected youth and young adults in Kenya. Public Health Action. 2016. Jun 21;6(2):142–6. 10.5588/pha.16.0021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Mandalakas AM, Kay AW, Bacha JM, Devezin T, Golin R, Simon KR, et al. Tuberculosis among children and adolescents at HIV treatment centers in sub-Saharan Africa. Emerg Infect Dis. 2020. Dec;26(12):2933–43. 10.3201/eid2612.202245 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Patel MR, Yotebieng M, Behets F, Vanden Driessche K, Nana M, Van Rie A. Outcomes of integrated treatment for tuberculosis and HIV in children at the primary health care level. Int J Tuberc Lung Dis. 2013. Sep;17(9):1206–11. 10.5588/ijtld.12.0833 [DOI] [PubMed] [Google Scholar]
  • 52.Reif LK, Rivera V, Bertrand R, Rouzier V, Kutscher E, Walsh K, et al. Outcomes across the tuberculosis care continuum among adolescents in Haiti. Public Health Action. 2018. Sep 21;8(3):103–9. 10.5588/pha.18.0021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Htet KKK, Liabsuetrakul T, Thein S, McNeil EB, Chongsuvivatwong V. Improving detection of tuberculosis among household contacts of index tuberculosis patients by an integrated approach in Myanmar: a cross-sectional study. BMC Infect Dis. 2018. Dec 14;18(1):660. 10.1186/s12879-018-3586-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Imsanguan W, Bupachat S, Wanchaithanawong V, Luangjina S, Thawtheong S, Nedsuwan S, et al. Contact tracing for tuberculosis, Thailand. Bull World Health Organ. 2020. Mar 1;98(3):212–8. 10.2471/BLT.19.239293 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Demissie M, Getahun H, Lindtjørn B. Community tuberculosis care through “TB clubs” in rural North Ethiopia. Soc Sci Med. 2003. May;56(10):2009–18. 10.1016/S0277-9536(02)00182-X [DOI] [PubMed] [Google Scholar]
  • 56.Oyieng’o D, Park P, Gardner A, Kisang G, Diero L, Sitienei J, et al. Community-based treatment of multidrug-resistant tuberculosis: early experience and results from Western Kenya. Public Health Action. 2012. Jun 21;2(2):38–42. 10.5588/pha.12.0002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Satti H, McLaughlin MM, Omotayo DB, Keshavjee S, Becerra MC, Mukherjee JS, et al. Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence. PLoS One. 2012;7(5):e37114. 10.1371/journal.pone.0037114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Wai PP, Shewade HD, Kyaw NTT, Kyaw KWY, Thein S, Si Thu A, et al. Patients with MDR-TB on domiciliary care in programmatic settings in Myanmar: effect of a support package on preventing early deaths. PLoS One. 2017. Dec 20;12(12):e0187223. 10.1371/journal.pone.0187223 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Dick J, Schoeman JH, Mohammed A, Lombard C. Tuberculosis in the community: 1. Evaluation of a volunteer health worker programme to enhance adherence to anti-tuberculosis treatment. Tuber Lung Dis. 1996. Jun;77(3):274–9. 10.1016/S0962-8479(96)90013-1 [DOI] [PubMed] [Google Scholar]
  • 60.Soomro MH, Qadeer E, Khan MA, Morkve O. Treatment supporters and their impact on treatment outcomes in routine tuberculosis program conditions in Rawalpindi district, Pakistan. Tanaffos. 2012;11(3):15–22. [PMC free article] [PubMed] [Google Scholar]
  • 61.van den Boogaard J, Lyimo R, Irongo CF, Boeree MJ, Schaalma H, Aarnoutse RE, et al. Community vs. facility-based directly observed treatment for tuberculosis in Tanzania’s Kilimanjaro region. Int J Tuberc Lung Dis. 2009. Dec;13(12):1524–9. [PubMed] [Google Scholar]
  • 62.Mesic A, Khan WH, Lenglet A, Lynen L, Ishaq S, Phyu EHH, et al. Translating drug resistant tuberculosis treatment guidelines to reality in war-torn Kandahar, Afghanistan: a retrospective cohort study. PLoS One. 2020. Aug 21;15(8):e0237787. 10.1371/journal.pone.0237787 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Yuen CM, Millones AK, Contreras CC, Lecca L, Becerra MC, Keshavjee S. Tuberculosis household accompaniment to improve the contact management cascade: a prospective cohort study. PLoS One. 2019. May 17;14(5):e0217104. 10.1371/journal.pone.0217104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Triasih R, Padmawati RS, Duke T, Robertson C, Sawyer SM, Graham SM. A mixed-methods evaluation of adherence to preventive treatment among child tuberculosis contacts in Indonesia. Int J Tuberc Lung Dis. 2016. Aug;20(8):1078–83. 10.5588/ijtld.15.0952 [DOI] [PubMed] [Google Scholar]
  • 65.Kay AW, Sandoval M, Mtetwa G, Mkhabela M, Ndlovu B, Devezin T, et al. Vikela Ekhaya: a novel, community-based, tuberculosis contact management program in a high burden setting. Clin Infect Dis. 2022. May 3;74(9):1631–8. 10.1093/cid/ciab652 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Dongo JP, Graham SM, Nsonga J, Wabwire-Mangen F, Maleche-Obimbo E, Mupere E, et al. Implementation of an effective decentralised programme for detection, treatment and prevention of tuberculosis in children. Trop Med Infect Dis. 2021. Jul 14;6(3):131. 10.3390/tropicalmed6030131 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Malik AA, Hussain H, Creswell J, Siddiqui S, Ahmed JF, Madhani F, et al. The impact of funding on childhood TB case detection in Pakistan. Trop Med Infect Dis. 2019. Dec 15;4(4):146. 10.3390/tropicalmed4040146 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Shrestha S, Kendall EA, Chang R, Joseph R, Kasaie P, Gillini L, et al. Achieving a “step change” in the tuberculosis epidemic through comprehensive community-wide intervention: a model-based analysis. BMC Med. 2021. Oct 14;19(1):244. 10.1186/s12916-021-02110-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Denoeud-Ndam L, Otieno-Masaba R, Tchounga B, Machekano R, Simo L, Mboya JP, et al. ; INPUT Study Group. Integrating pediatric TB services into child healthcare services in Africa: study protocol for the INPUT cluster-randomized stepped wedge trial. BMC Public Health. 2020. May 6;20(1):623. 10.1186/s12889-020-08741-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Hirsch-Moverman Y. Flexible child contact management framework. Int J Tuberc Lung Dis. 2020;24(10) Suppl 2:S4. [Google Scholar]
  • 71.Sawyer SM, Drew S, Yeo MS, Britto MT. Adolescents with a chronic condition: challenges living, challenges treating. Lancet. 2007. Apr 28;369(9571):1481–9. 10.1016/S0140-6736(07)60370-5 [DOI] [PubMed] [Google Scholar]
  • 72.Enane LA, Vreeman RC, Foster C. Retention and adherence: global challenges for the long-term care of adolescents and young adults living with HIV. Curr Opin HIV AIDS. 2018. May;13(3):212–19. 10.1097/COH.0000000000000459 [DOI] [PubMed] [Google Scholar]
  • 73.Teasdale CA, Alwar T, Chege D, Fayorsey R, Hawken MP, Abrams EJ. Impact of youth and adolescent friendly services on retention of 10-24-year-olds in HIV care and treatment programs in Nyanza, Kenya. J Acquir Immune Defic Syndr. 2016. Feb 1;71(2):e56–9. 10.1097/QAI.0000000000000877 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Snow KJ, Cruz AT, Seddon JA, Ferrand RA, Chiang SS, Hughes JA, et al. Adolescent tuberculosis. Lancet Child Adolesc Health. 2020. Jan;4(1):68–79. 10.1016/S2352-4642(19)30337-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Enane LA, Eby J, Arscott-Mills T, Argabright S, Caiphus C, Kgwaadira B, et al. TB and TB-HIV care for adolescents and young adults. Int J Tuberc Lung Dis. 2020. Feb 1;24(2):240–9. 10.5588/ijtld.19.0416 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.WHO consolidated guidelines on tuberculosis. Module 5: management of tuberculosis in children and adolescents. Geneva: World Health Organization; 2022. Available from: https://www.who.int/publications/i/item/9789240046764http://[cited 2022 Sep 28]. [PubMed]
  • 77.WHO operational handbook on tuberculosis. Module 5: management of tuberculosis in children and adolescents. Geneva: World Health Organization; 2022. Available from: https://www.who.int/publications/i/item/9789240046832. [cited 2022 Sep 28]. [PubMed]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES